Wound Infiltration With Sodium Diclofenac vs Bupivacaine for Postoperative Pain Following Appendectomy (diclofenac)
Primary Purpose
Postoperative Pain
Status
Completed
Phase
Phase 3
Locations
Study Type
Interventional
Intervention
Bupivacaine
Sodium diclofenac
Sponsored by
About this trial
This is an interventional treatment trial for Postoperative Pain
Eligibility Criteria
Inclusion Criteria:
- American Society Anesthesiologist I- II
- aged 18 and 65
- both sexes
- patients diagnosed with acute appendicitis operated under general anesthesia
Exclusion Criteria:
- Patients known to any allergy of the drugs used in the study
- Different incision approach Mc Burney
- Some intraoperative surgical complications
- Pregnant patients
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
Experimental
Experimental
Experimental
Arm Label
Bupivacaine
Bupivacaine, sodium diclofenac
Sodium diclofenac
Arm Description
A dilution of Bupivacaine 0,25% , 15 ml was infiltrated in surgical wound after close the aponeurosis
A dilution of Bupivacaine 0,25% and sodium diclofenac 75 mgr, was infiltrated in surgical wound after close the aponeurosis
A dilution of sodium diclofenac 75 mgrs (3ml) and 12 ml of solution 0,9% was infiltrated in surgical wound after close the aponeurosis
Outcomes
Primary Outcome Measures
rest and dynamic postoperative pain with visual analogue scale
rescue analgesic consumption
appearance of bowel sounds
auscultation of bowel sounds
changes in rest and dynamic postoperative pain with visual analogue scale
Secondary Outcome Measures
number of participants with skin suture removal after 10 days
Full Information
NCT ID
NCT02752971
First Posted
March 20, 2016
Last Updated
April 26, 2016
Sponsor
Hospital Central Dr. Luis Ortega
1. Study Identification
Unique Protocol Identification Number
NCT02752971
Brief Title
Wound Infiltration With Sodium Diclofenac vs Bupivacaine for Postoperative Pain Following Appendectomy
Acronym
diclofenac
Official Title
Surgical Wound Infiltration With Sodium Diclofenac Versus Bupivacaine in the Treatment of Acute Postoperative Pain Following Appendectomy
Study Type
Interventional
2. Study Status
Record Verification Date
April 2016
Overall Recruitment Status
Completed
Study Start Date
February 2015 (undefined)
Primary Completion Date
February 2016 (Actual)
Study Completion Date
undefined (undefined)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Hospital Central Dr. Luis Ortega
4. Oversight
5. Study Description
Brief Summary
The infiltration of the surgical wound is an effective strategy for postoperative analgesia. Nonsteroidal antiinflammatories are useful in this way.
Objective: To compare the analgesic effectiveness of diclofenac sodium, bupivacaine or bupivacaine plus diclofenac sodium infiltrating wound appendectomies.
Method: Comparative, double blind, American Society Anesthesiologist classification I-II,18-65años. Group 1 (Bupivacaine n = 14), Group 2 (Diclofenac Sodium n = 14), Group 3 (Bupivacaine + Diclofenac Sodium n = 15). Pain at rest and dynamic, rescue analgesic consumption in Post Anesthesia Care Unit (PACU) and 24 hours after surgery were evaluated.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Postoperative Pain
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Crossover Assignment
Masking
ParticipantCare ProviderInvestigator
Allocation
Randomized
Enrollment
43 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Bupivacaine
Arm Type
Experimental
Arm Description
A dilution of Bupivacaine 0,25% , 15 ml was infiltrated in surgical wound after close the aponeurosis
Arm Title
Bupivacaine, sodium diclofenac
Arm Type
Experimental
Arm Description
A dilution of Bupivacaine 0,25% and sodium diclofenac 75 mgr, was infiltrated in surgical wound after close the aponeurosis
Arm Title
Sodium diclofenac
Arm Type
Experimental
Arm Description
A dilution of sodium diclofenac 75 mgrs (3ml) and 12 ml of solution 0,9% was infiltrated in surgical wound after close the aponeurosis
Intervention Type
Drug
Intervention Name(s)
Bupivacaine
Intervention Type
Drug
Intervention Name(s)
Sodium diclofenac
Primary Outcome Measure Information:
Title
rest and dynamic postoperative pain with visual analogue scale
Time Frame
24 hours of postoperative period
Title
rescue analgesic consumption
Time Frame
24 hours of postoperative period
Title
appearance of bowel sounds
Description
auscultation of bowel sounds
Time Frame
24 hours of postoperative period
Title
changes in rest and dynamic postoperative pain with visual analogue scale
Time Frame
24 hours of postoperative pain
Secondary Outcome Measure Information:
Title
number of participants with skin suture removal after 10 days
Time Frame
10 days of postoperative pain
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
American Society Anesthesiologist I- II
aged 18 and 65
both sexes
patients diagnosed with acute appendicitis operated under general anesthesia
Exclusion Criteria:
Patients known to any allergy of the drugs used in the study
Different incision approach Mc Burney
Some intraoperative surgical complications
Pregnant patients
12. IPD Sharing Statement
Learn more about this trial
Wound Infiltration With Sodium Diclofenac vs Bupivacaine for Postoperative Pain Following Appendectomy
We'll reach out to this number within 24 hrs